Prepare an Executive Research Briefing Without Predicting Scientific Outcomes
Turn a broad institutional strategy request into an agenda built from available evidence and a focused next session.
A vice president for research asks you for a short briefing that connects your platform evaluation to institutional priorities. The request sounds simple. It is not. The moment you predict which research area will benefit most, you have stepped past your role and put your credibility at risk. Handle the conversation well and you become the account executive who understands how research institutions actually make decisions. Handle it poorly and you become the vendor who claims to know the science better than the scientists running it.
Why This Briefing Goes Wrong
Executives ask broad questions because they are testing how you think, not because they expect you to hand them a forecast. Under pressure to sound prepared, many account executives fill the gap with a confident guess. They name a research area, a therapeutic focus, or a department, and imply that adopting the platform will move that work forward faster than anything else.
That answer feels helpful in the moment. It backfires fast. Research strategy and funding priorities belong to the institution, not to the vendor sitting across the table. An executive who hears you predict a scientific outcome will discount everything else you say in the meeting, because you just showed that you will overstate what your product can promise. Scientists who later hear about the claim will push back harder, and your champion inside the account will have to defend a statement you should never have made.
The fix is not to dodge the question. It is to redirect it toward what you actually know, which is the platform, the workflow, and the evidence you can verify.
Prepare Before You Build a Single Slide
Do not open a slide deck until you have answers to a short set of questions. Ask the executive which published or stated priorities they want the briefing to address. Ask what decision the briefing needs to inform, since a briefing that supports a budget request looks different from one that supports a governance review. Ask which leaders need to attend, and why each of them belongs in the room.
Confirm what kind of session this is. Some executives want a workflow overview that shows how the platform fits daily lab operations. Others want evaluation criteria, a governance discussion about data access and compliance, or a plain review of the evidence available so far. Guessing wrong on this point wastes the meeting and forces a second one to cover what the first one missed.
Review the account history before you walk in. If a lab recently needed rushed equipment or reagents, the way your team handled that request may already shape how this executive views your reliability, and the approach described in Respond to an Expedited Shipment Request With Verified Options applies here too, since both situations reward answers grounded in verified facts instead of reassurance. If departments recently merged or leadership changed, confirm your contact map is current using the same discipline covered in Refresh an Account Contact Map After a Faculty Mergerso you are not presenting to the wrong audience or missing a decision maker who now owns the topic.
Once you know the priorities, the decision, and the audience, build the agenda around decision questions rather than around product claims. Each topic should answer something the executive needs to decide, not something you want to showcase.
What to Say in the Room
The executive opens with the question you prepared for. "Can you tell me which research area will benefit most from this platform." You do not guess. "I would not want to predict a scientific outcome. That call belongs to your team. If you tell me the priority themes your institution is working from right now, I can build a briefing that ties those themes to the workflows you want evaluated and to the evidence we have for each one."
The executive names two themes, translational research and the capacity of the shared core facilities. You confirm you heard both correctly, then ask who else needs to be in the room. "Given those two themes, would it help to have someone from core facilities operations join, along with whoever owns translational research funding decisions." The executive agrees and adds the dean and the research strategy lead to the invitation.
A few days later, in a short check in call, the executive asks a harder version of the same question. "Between the two, which one should we prioritize for the pilot." You hold the line again, but you give them something real to work with. "That is your call to make, and I do not have the standing to make it for you. What I can tell you is which of the two has more available evidence from comparable labs, and which one would need a longer evaluation window because of how the core facility workflows are structured. I can lay both paths out in the briefing so your team can weigh them."
That exchange does two things. It protects you from a claim you cannot back up, and it gives the executive something more useful than a guess, a clear picture of tradeoffs they can act on.
Mistakes That Undercut Your Credibility
A few habits turn this kind of briefing into a liability instead of an asset. First, naming a favored research area, even informally or as a passing comment, hands the executive a reason to distrust the rest of the presentation. Second, using unverified product claims to fill gaps in the evidence, since a research audience will catch an overstated claim faster than almost any other buyer type. Third, building the agenda around your product roadmap instead of the institution's stated priorities, which turns a strategy briefing into a sales pitch and signals that you were not listening. Fourth, inviting a broad group without confirming that each person owns the information the meeting needs, which wastes senior time and makes the next meeting harder to schedule.
Each of these mistakes comes from the same source, a desire to seem more certain than the situation allows. Staying inside your role is not a weakness. It is what makes the rest of your input trustworthy.
Practice and Score the Conversation
This is a hard conversation to get right on instinct alone, because the pressure to answer confidently is real and the line between a workflow observation and a scientific prediction is not always obvious in the moment. Rehearsing it with a manager or through a tool like DealSpeak, where an AI counterpart plays the executive and pushes on the prediction question the way a real one would, gives you a chance to find your footing before it matters.
When you score the practice run, check three things. Did you redirect the prediction question without dodging it or sounding evasive. Did every agenda item trace back to a priority the executive actually stated, rather than one you assumed. Did the proposed attendees each own information the briefing needs, instead of being invited out of habit. A manager reviewing the recording should flag any moment where confidence crept past what the evidence supports.
Close
An executive research briefing succeeds when it respects who owns the decision. Your job is to bring organized, verified information to the table, not a forecast. Browse more scenarios like this one in Biotechnology practice conversationsand rehearse the harder follow up questions before an executive asks them for real.
Practice these next
Prepare an executive working session that connects stated priorities with the centers and stakeholders involved.
Connect an operational demonstration request to the customer’s actual decision process.
Help a research account executive turn a broad committee request into a bounded platform evaluation.
Guide a concern about computing capacity toward a technical discovery session that assesses whether the platform fits the laboratory’s computing environment.
Keep an exploratory consortium conversation separate from pricing or commitments while member institutions retain their own approvals.
Help a core facility define its real intake workflow and decision criteria before discussing a research platform evaluation.